Dr Chetan Deshmukh
Dr. Chetan Deshmukh, an esteemed Consultant, serves at prestigious medical institutions in Pune with an overall 23 years of experience in medical oncology. With expertise honed over the years, he contributes significantly to Deenanath Mangeshkar Hospital and Ruby Hall Clinic. His dedication extends to his own Deshmukh Clinic and Research Centre, where he pioneers innovative approaches to healthcare. Dr. Deshmukh’s commitment to patient care and medical advancement stands as a pioneer of hope in Pune’s healthcare landscape.
Specialization
Dr. Chetan Deshmukh is a medical specialist in the following major interventions including –
- Blood Cancer
- Breast Cancer
- Gastrointestinal Cancer
- Gynae Oncology
- Head & Neck Cancer
- Hepatobiliary Cancer
- Lung Cancer
- Medical Oncology
- Ocular Oncology
- Radiation Oncology
- Uro Oncology
Education
- MBBS, MD, DNB, DM
- Trained at Tata Memorial Hospital
- Trained in Cancer Clinical Research at Cairns, Australia
Career
- Assistant Prof in Medical Oncology: Sassoon General Hospital, Pune
- Consultant Medical Oncologist: Deenanath Mangeshkar Hospital & Research Centre, Pune
- Director: Deshmukh Clinic and Research Centre, Pune
- Consultant Medical Oncologist: Prashanti Cancer Foundation, Ruby Hall Clinic, Pune.
Publications
Dr. Chetan Deshmukh has 70 published articles in national and international journals some of which are mentioned below –
- Impact of oncoplasty in increasing breast conservation rates Post neo-adjuvant chemotherapy
- Integrative Cancer Care Unit: An institutional experiment towards Integrative Oncology
- Therapeutic mammoplasty: a “wise” oncoplastic choice—lessons from the largest single-center cohort from Asia
- P225 Impact Of Oncoplasty in Increasing Breast Conservation Rates Post Neo-Adjuvant Chemotherapy
- Once-a-Day Ceftriaxone–Amikacin Combination as Empiric Antibiotic Therapy to Enable Outpatient Management of Febrile Neutropenia in Children—16-Year Experience from a Single Institute
- Management of human epidermal growth factor receptor 2-negative metastatic breast cancer: Role of poly adenosine diphosphate (ADP-ribose) polymerase inhibitors
- Bone marrow morphological changes in patients of chronic myeloid leukemia treated with imatinib mesylate
- NGS-based profiling of key cancer genes in Indian triple-negative breast cancer patients reinforces molecular heterogeneity of the disease
- Cancer Patient Management during COVID-19 Pandemic: An Audit of a Single-Surgeon Unit in a COVID-Hotspot
- Breast Cancer Biobank from a Single Institutional cohort in an Urban Setting in India: Tumor Characteristics and Survival Outcomes.
- Outcome of COVID-19 Infection in Cancer Patients in Pune
Dr. Deshmukh’s expertise encompasses the latest advancements in oncology, offering patients hope and support in their journey toward improved health. He is dedicated to enhancing the quality of life for cancer patients. Through personalized treatment plans and comprehensive care, he strives to alleviate suffering and promote well-being. His commitment to excellence and patient-centered approach make him a valuable asset in the fight against cancer.